SCHEMBL6035940

SCHEMBL6035940

COc1cccc(Cc2ccncc2)c1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.50
ROCK1 Q13464 2/20 0.50
RAB9A P51151 1/20 0.50
LMNA P02545 1/20 0.48
KDM4E B2RXH2 2/20 0.48
MAPT P10636 2/20 0.48
HSD17B10 Q99714 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
HTR1A P08908 1/20 0.46
ADRA1D P25100 1/20 0.46
ADRA1A P35348 1/20 0.46
ADRA1B P35368 1/20 0.46
ABCB1 P08183 4/20 0.46
ABCG2 Q9UNQ0 1/20 0.46
GAA P10253 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9265704 0.84 LTA4H (0.51) LMNAKDM4EMAPTHTR1AADRA1D
SCHEMBL3301381 0.84 ABCB1 (0.60) KDM4EHTR1AADRA1DADRA1AADRA1B
SCHEMBL3306584 0.82 SMN1; SMN2 (0.54) RAB9ALMNAKDM4EL3MBTL1ABCB1
SCHEMBL11434004 0.80 CYP19A1 (0.50) RAB9AKDM4EMAPTHTR1AADRA1D
SCHEMBL9185713 0.77 CA2 (0.61) RAB9AKDM4EABCB1ABCG2GAA
SCHEMBL27950805 0.76 BCHE (0.50) RAB9AKDM4EHTR1AADRA1DADRA1A
SCHEMBL27950804 0.75 SLC5A1 (0.44) RAB9AKDM4EMAPTL3MBTL1HTR1A
SCHEMBL7649026 0.74 KDM4E (0.70) RAB9AKDM4EL3MBTL1HTR1AABCB1
SCHEMBL7000988 0.74 ROCK2 (0.48) ROCK2ROCK1RAB9AKDM4EMAPT
SCHEMBL8092420 0.74 KMT2A (0.54) ROCK2ROCK1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1734037-A2 Processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol\ Aventis Pharmaceuticals Inc. (US) 2006-12-20 EP disclosed